Recruiting PHASE1 INTERVENTIONAL 1-arm NCT03240328

The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

The Effect of CAR-T Cell Therapy on the Reconstitution of HIV-specific Immune Function

Sponsor: Guangzhou 8th People's Hospital

Conditions HIV/AIDS

Interventions CAR-T cells

Updated 11 times since 2017 Last updated: Sep 13, 2022 Started: Oct 4, 2017 Primary completion: Dec 31, 2023 Completion: Dec 31, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on HIV/AIDS, this trial is actively recruiting participants. The trial is conducted by Guangzhou 8th People's Hospital and has accumulated 11 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Sep 2022 — Jul 2024 [monthly]

Recruiting PHASE1
Sep 2021 — Sep 2022 [monthly]

Recruiting PHASE1
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE1

▶ Show 6 earlier versions

Aug 2020 — Jan 2021 [monthly]

Recruiting PHASE1
Mar 2020 — Aug 2020 [monthly]

Recruiting PHASE1
Jul 2019 — Mar 2020 [monthly]

Recruiting PHASE1
Jun 2018 — Jul 2019 [monthly]

Recruiting PHASE1
May 2018 — Jun 2018 [monthly]

Recruiting PHASE1

Status: Not Yet Recruiting → Recruiting
Sep 2017 — May 2018 [monthly]

Not Yet Recruiting PHASE1

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou 8th People's Hospital
Sun Yat-sen University

Data source: Guangzhou 8th People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China